Korea Seeks New Law To Support Orphan Drugs, Ease Supply Disruptions
This article was originally published in PharmAsia News
Executive Summary
Amid continued disruptions in medicine supplies and growing need to develop orphan drugs, South Korea’s government plans to submit a bill to parliament that will enable it to designate "innovative medicines" for the treatment of fatal or incurable diseases, help speed up the development and approval of innovative drugs, as well as ease supply disruptions.